Ascendis_FINAL_LOGO_7.23.15.png
Ascendis Pharma to Report Second Quarter 2024 Financial Results and Provide Business Update on September 3, 2024
August 28, 2024 08:30 ET | Ascendis Pharma
COPENHAGEN, Denmark, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter 2024 financial results and provide a business update on...
Aprea Logo.jpg
Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
August 28, 2024 08:30 ET | Aprea Therapeutics
DOYLESTOWN, Pa., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology...
Intra-Cellular_Logo_RGB_ALT.jpg
Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences
August 28, 2024 08:00 ET | Intra-Cellular Therapies Inc.
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central...
Gabelli Funds.png
Gabelli Funds to Host 30th Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 5, 2024
August 28, 2024 08:00 ET | Gabelli Funds
RYE, N.Y., Aug. 28, 2024 (GLOBE NEWSWIRE) --  Gabelli Funds, LLC, is hosting our annual Aerospace & Defense Symposium at The Harvard Club in New York City on September 5th. The conference will...
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 28, 2024 08:00 ET | Conduit Pharmaceuticals
SAN DIEGO and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced it will be participating in the H.C. Wainwright 26th...
Logo.jpg
Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 28, 2024 08:00 ET | Elicio Therapeutics Inc.
BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel...
accolade_logotype_nd_color-2913x728-8b3ff78.jpg
Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference
August 28, 2024 08:00 ET | Accolade, Inc.
SEATTLE, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on...
liquidia-new-logo.png
Liquidia to Present at Upcoming Investor Conferences
August 28, 2024 08:00 ET | Liquidia Corporation
Liquidia Corporation (LQDA) announced today that the company will present at two investor conferences this September.
FTC Solar Logo.jpg
FTC Solar to Participate at RE+ Event September 9-12
August 28, 2024 08:00 ET | FTC Solar, Inc
AUSTIN, Texas, Aug. 28, 2024 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading global provider of solar tracker systems, software, and engineering services, is pleased to announce its...
Pliant_logo_300x300.jpg
Pliant Therapeutics to Participate in Upcoming Investor Events
August 28, 2024 08:00 ET | Pliant Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel...